« Home « Chủ đề hoạt chất dược phẩm

Chủ đề : hoạt chất dược phẩm


Có 160+ tài liệu thuộc chủ đề "hoạt chất dược phẩm"

Pharmaceutical Substances Syntheses, Patents, Applications - Part 140

tailieu.vn

RN MF: C2,H2,NOq. RN MF: C2,H2,N03 MW monohydrochloride. RN MF: C2,H2,NO3. 10.7.1989).. 127 mglkg (M, i.v. RN MF: C,,HzlN03. 260 mg/kg (M, i.p. 921 mg/kg (M, s.c.). 260 mglkg (M, s.c.). Use: narcotic antagonist RN MF: C2,H2,NO4 MW: 341.41 EINECS: 240-649-9. 551 mg/kg (M, s.c.). RN MF: C20H23N04 . >566 mg/kg (M, i.p.). RN MF: C,,H4,04 MW: 506.73 EINECS CN...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 141

tailieu.vn

7.12.1967).. 16.12.1980. 16.9.1985. 12.7.1988. 12.8.1986. 8.10.1985. 22.3.1985).. Use: antimigraine agent, 5-HT,-agonist RN MF: C,,HzsN30zS MW: 335.47. RN MF: C,,H,,N,O,S . RN MF: C,,H2,N302S . S01AA10 Use: fungicidal antibiotic RN MF: C,,H,,NO,, MW: 665.73 EINECS: 231-683-5. RN MF: C,,H,NO, MW: 317.43. 27.3.1985).. Use: anti-emetic, 5-HT3-antagonist RN MF: C17H20CIN,03 MW. RN MF: CI7H2,C1N3O3 . RN MF: C17H20CIN303 MW enantiomer monohydrochloride. RN MF:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 142

tailieu.vn

Use: antidepressant, 5-HT2A-antagonist RN MF: C2SH,2ClN,02~ HCI MW: 506.48. RN MF: C2SH,,CIN,02 MW: 470.02. 3.12.1990. 3.12.1990).. Use: analgesic, muscle relaxant RN MF: C,,HlyNO MW: 253.35 EINECS: 237-148-2. RN MF: C,,H,,NO. Nelfinavir mesylate. Use: antiviral, HIV-protease inhibitor RN MF: C3,H4,N304S . I Nelfinavir mesylate. Use: antipsychotic, selective D,-antagonist RN MF: C2,H2,C1N,0, MW: 387.91. 22.12.1978. 20.12.1978. RN MF: C,7H22N20S . RN MF:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 143

tailieu.vn

Use: antiviral, anti-AIDS therapeutic, reverse transcriptase inhibitor RN MF: C,,H,,N,O MW: 266.30. 4.12.1992. 4.12.1994).. 200 mg Trade Name(s):. Use: antiallergic, bronchodilator, sedative RN MF: CzOHz5FN40 MW: 356.45 EINECS: 248-431-5. LD,: 145 mglkg (M, i.v. 890 mglkg (M, p.0.). Trade Name(s):. Use: calcium antagonist RN MF: C2,HZyN3O6 MW: 479.53 EINECS: 259-932-3. 9.7 mglkg (M, i.v. 480 mglkg (M, p.0.);. RN MF:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 144

tailieu.vn

5 mg, 10 mg Trade Name(s):. 1.68 glkg (R, s.c.) CN: 3-pyridinecarboxamide. nicotinic acid. 200 mg Trade Name(s):. 1432 N Nicotinic acid. Nicotinic acid ATC: A ~ I H A O. 3720 mglkg (M, p.0.);. RN MF: C12H,MgN20, MW: 268.51 EINECS LD. Nicotinic acid. 500 mg Trade Name(s):. Nicotinic acid benzyl ester. 100 mglkg (M, i.v. 2188 mglkg (M, p.0.)...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 145

tailieu.vn

250 mg/ml Trade Name(s):. treatment of prostatic carcinoma) RN MF: C,,H,,F,N,04 MW: 317.22. 200 mg/kg (M, p.0.);. 50 mg Trade Name(s):. 25.6.1985. Nimesulide N 1443 medical use for treatment of arteriosclerosis:. 7.12.1985. medical use for treatment of cerebral dysfunction:. 8 mg, 16 mg Trade Name(s):. 100 mg, 200 mg Trade Name(s):. RN MF: C,,H,,N303 MW: 295.30 EINECS LD. 3 mg,...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 146

tailieu.vn

7.12.1960. 25.10.1972. 5 mg, 10 mg Trade Name(s):. Use: alcohol deterrent RN MF: CloH,N404 MW: 248.20 EINECS: 244-542-8. 9.10.1976).. Use: calcium antagonist, antihypertensive RN MF: CI,H2,N,O, MW: 360.37 EINECS: 254-513-1. 34.5 mglkg (M, i.v. 2540 mglkg (M, p.0.);. 12.6 mglkg (R, i.v. 10.4.1971).. Nitrofural N 1453 Trade Name(s):. 0.2 gllOO g Trade Name(s):. 10.9.1968. 24.10.1978. 50 mg Trade Name(s):. Use:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 147

tailieu.vn

CN: (17a)-17-hydroxy-19-norpregn-4-en-20-yn-3-one. 0.35 mg, 0.5 mg (also in comb.) Trade Name(s):. CN: (17a)- 17-(acetyloxy)-19-norpregn-4-en-20-yn-3-one. CN: (17a)-17-[(l -oxoheptyl)oxy]-19-norpregn-4-en-20-yn-3-one. CN: (17a)-17-hydroxy-19-norpregn-5(10)-en-20-yn-3-one. 390 mglkg (R, p.0.) CN: a-(aminomethy1)-3-hydroxybenzenemethanol hydrochIoride

Pharmaceutical Substances Syntheses, Patents, Applications - Part 148

tailieu.vn

14.12.197 1. Trade Name(s):. 275 mglkg (M, sx.). RN MF: C,H,,NO . 10.3.1984. 12.3.1983).. HCI MW: 299.85 EINECS LDso: 18.7 mglkg (M, i.v. 260 mglkg (M, p.0.);. 26.1.1962).. 13.3.1962. 6.10.1961).. 15.1.1962).. 10.8.1962. 26.2.1962).. 12.3.1963. 12.4.1969. 12.4.1968).. 10.10.1961. 407 mglkg (M, i.v. 1500 mglkg (M, p.0.). RN MF: C3,H35N,Na0,, MW: 634.61 EINECS LDo: 407 mglkg (M, i.v. 16.2.1960. 27.12.1960. 26.12.1957. 14.8.1962....

Pharmaceutical Substances Syntheses, Patents, Applications - Part 149

tailieu.vn

30.10.1991. 25.4.1990).. 25.9.1996. 24.3.1995).. 20.7.1993. 25.9.1996).. 22.9.1997. 23.9.1996).. 20.9.1996. 22.3.1996. ATC: JOlFAOS Use: antibiotic RN MF: C,,H,,NO,, MW: 687.87 EINECS LD. 440 mglkg (R, i.v. 6700 mglkg (R, p.0.). RN MF: C,,H,,NO,Z . 480 mglkg (R, i.v.). 12.3.1957).. RN MF: C,,H,,N40~ HCI MW: 286.72 LD. 7804 mglkg (R, p.0.);. RN MF: Cl4H,,N40 MW: 250.26. 22.9.1986. 22.9.1986).. et al. 25.3.1986. 26.3.1985).....

Pharmaceutical Substances Syntheses, Patents, Applications - Part 151

tailieu.vn

RN MF: C,,H,,N,,0,2S, MW: 1042.21 EINECS CN: 8-L-ornithinevasopressin. 770mg/kg(M, i.v.);2g/kg (M.p.0.). RN MF: C,H3KN204 MW: 194.19 EINECS LD. RN MF: C,,H,MgN40R MW: 334.48 zinc salt. RN MF: C,,H,N,O,Zn MW: 375.57 EINECS choline orotate. RN MF: CSH,,NO . RN MF: ClnH2,N0 . RN MF: C,,H2,N204 MW: 312.41. RN MF: C,,H2,N2O4 . RN MF: Cl,H2nN204 . RN MF: C,,H2,N204. (-)-quinic acid 2.2-dirnethoxy-...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 152

tailieu.vn

Use: anti-inflammatory RN MF: C,,H,,N03 MW: 293.32 EINECS: 244-296-1. 2 glkg (dog, p.0.) CN: 4,5-diphenyl-2-oxazolepropanoic acid. Use: antiallergic RN MF: C,H,,N,O MW: 426.56 EINECS LD. ATC: N03AF02 Use: anticonvulsant RN MF: C,,H,,N202 MW: 252.27 EINECS: 249-188-8. 10.3.1969).. 24.10.1980. 27.10.1980. 30.10.1979. RN MF: C2,,H,,NO3 . RN MF: C28H41N303 . (in comb.) 10 mgI5 ml. Use: antimigraine agent RN MF: C21H21N02 MW:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 153

tailieu.vn

LJse: anticholinergic, antispasmodic RN MF: C,,H,,BrN03S MW: 428.39 EINECS: 241-688-4. 27.5 mglkg (M, i.v. 1050 mglkg (M, p.0.). Use: antidepressant (psy siological serotonin precursor) RN MF: C,,H,,N,O, MW: 220.23 EINECS . LD,: 375 mglkg (M, i.v. 243 m g k g (R, p.0.) CN: 5-hydroxy-L-tryptophan. Use: anticholinergic, antiasthmatic RN MF: C19H,BrN0, MW: 412.32 EINECS: 250-113-6. 679 mglkg (M, p.0.);. RN...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 154

tailieu.vn

Use: coronary therapeutic RN MF: CI9H2,NO3 MW: 313.40. RN MF: C,,H23N03 . 510 mglkg (M, p.0.);. (vasoconstrictor) RN MF: C16HHN20 MW: 260.38 EINECS: 216-079-1. RN MF: Cl,H24N20 . gel 0.5 mg. 172 mglkg (M, i.v.). IJse: anti-emetic RN MF: C,,,H,N40S MW: 370.52. RN MF: C2,H2,N40S~ 2HCl MW: 443.44 EINECS LD. 735 mglkg (M, p.0.);. 330 mglkg (M, p.0.);. RN MF:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 155

tailieu.vn

et al.: Science (Washington, D.C.) (SCIEAS . et al.: J. 22.9.1992. et al.: Bioorg. 17.8.1992. 16.9.1993. 10.3.1992).. 29.3.1993).. et al.: Tetrahedron: Asymmetry (TASYE . et al.: Biotechnol. el al.: Tetrahedron (TETRAB . et al.: Tetrahedron Lett. et al.: Expert Opin. et al.: Angew. et al.: Nature (London) (NATUAS . 23.6.1992. 23.6.1992) Wessjohann, L.: Angew. 22.3.1993).. 12.1 1.1993. 12.5.1993).. 2.12.1993

Pharmaceutical Substances Syntheses, Patents, Applications - Part 156

tailieu.vn

Use: calcium metabolism rcgulator (treatment of Paget's disease, hypercalcemia of malignancy) RN MF: C,H,,NO,P, MW: 235.07 EINECS: 254-905-2. RN MF: C,H,NNa207P, MW: 279.03 EINECS: 260-647-1. 1.12.1975).. Use: ganglionic blockcr, anticonvulsant RN MF: C,5HmBr,N,0, MW: 732.68 EINECS: 239-532-5. Use: growth factor RN MF: C2,H,2N,0,S2 MW: 554.73 EINECS LD. 3400 mglkg (M, i.v. 6 0 mg Trade name!.^):. RN MF: C,,H14F,N,Na04S MW:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 157

tailieu.vn

30.4.1959. 12.5.1958).. 3.12.1962).. RN MF: C,,H,O, MW: 416.65. 12.9.1990. 13.2.1996).. 30.5.1997). ATC: A07AA06 Use: antibiotic RN MF: C23H4SN50L4 MW: 61 5.63 EINECS LD. RN MF: C,,H4,N,0,4~ xH,S04 MW: unspecified EINECS LD. 8.12.1959. 12.1.1959).. RN MF: C,,H,,FN03 MW: 329.37 LD. RN MF: C,9H2,FN03. 415 m d k g (R, p.0.) hydrochloride hydrate (2:l). RN MF: C,,HzoFNO,. RN MF: ClyH,,FN03 . RN...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 158

tailieu.vn

Use: fungicidal antibiotic RN MF: C,,H2,N03 MW: 291.39 EINECS . Use: antibiotic (gyrase inhibitor) RN MF: C,,H2,FN3O, MW: 333.36 EINECS: 274-611-8. RN MF: C,,H2,FN,0. 2500 mglkg (R, p.0.). Use: antiallergic RN MF: Cl0HRN6O MW: 228.22. RN MF: CloH,KN60 MW: 266.31 LD. 372 mglkg (R, 1.v. 687 mglkg (R, p a . ATC: N06BA05 Use: psychoenergetic RN MF: C9H8N,0, MW: 176.18...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 159

tailieu.vn

Use: gastric secretion diagnostic RN MF: C,,H,,N,O,S MW: 767.91 EINECS: 226-889-7. ATC: GO3 Use: progestogen RN MF: C,,H4,04 MW: 440.62. 2C2H604S MW: 592.69 EINECS LD5,: 15.1 mglkg (M, i.v.). Use: antispasmodic, anticholinergic RN MF: C,,H,,NO, M W 289.42 EINECS: 230-286-4. RN MF: C,,H,oN02. 435 mglkg (M, p.0.);. 205 mglkg (M, p.0.);. RN MF: C,,H2,N0 . 126 mglkg (M, s.c.). RN...